Azioni Aerie Pharmaceuticals, Inc.
Azioni
AERI
US00771V1089
Prodotti farmaceutici
Dirigenti | Titolo | Età | Da |
---|---|---|---|
David Endicott
CEO | Chief Executive Officer | 58 | 21/11/22 |
Andrew Allen
CMP | Compliance Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 01/03/22 |
Amministratori | Titolo | Età | Da |
---|---|---|---|
Ian Bell
BRD | Director/Board Member | 54 | 21/11/22 |
Chairman | 57 | 21/11/22 | |
Jonathan Balch
BRD | Director/Board Member | - | 21/11/22 |
Nome | Peso | AuM | Variaz. 1 gen. | Rating Invest. |
---|---|---|---|---|
0.02% | 509 M€ | -.--% |
Variaz. 1 gen. | Capi. | |
---|---|---|
+25,83% | 661 Mrd | |
+27,00% | 566 Mrd | |
-6,76% | 352 Mrd | |
+20,34% | 332 Mrd | |
+3,00% | 283 Mrd | |
+13,09% | 231 Mrd | |
+5,46% | 200 Mrd | |
-9,61% | 195 Mrd | |
-6,26% | 145 Mrd |